{"transactions":[{"id":1152457,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79919,"kind":"person","name":"Kawakami Mark","position":1,"cik":"0002030709","reported_name":"Kawakami Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-12T20:56:01.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 5/9/2025 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":33987,"derivative":{"exercise_price":3.88,"expiration_date":"2035-05-09","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-25-069633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030709/000095017025069633/ownership.xml","form_type":"4"}},{"id":1282300,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79919,"kind":"person","name":"Kawakami Mark","position":1,"cik":"0002030709","reported_name":"Kawakami Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-05T19:34:41.000Z","date":"2025-02-03","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":2.49,"value":1743.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/25 at a per share purchase price of $2.49 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from August 1, 2022 to February 1, 2025. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the respective offering date or purchase date, whichever is lower."}],"balance_after":2681,"source":{"system":"sec-edgar","filing":"0000950170-25-014814","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030709/000095017025014814/ownership.xml","form_type":"4"}},{"id":1426692,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79919,"kind":"person","name":"Kawakami Mark","position":1,"cik":"0002030709","reported_name":"Kawakami Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-21T18:26:11.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 8/19/2024 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":21487,"derivative":{"exercise_price":2.71,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-099605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030709/000095017024099605/ownership.xml","form_type":"4"}},{"id":1427942,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79919,"kind":"person","name":"Kawakami Mark","position":1,"cik":"0002030709","reported_name":"Kawakami Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-20T20:11:11.000Z","date":"2024-08-01","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":2.06,"value":1442.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 8/1/24 at a per share purchase price of $2.06 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from February 1, 2022 to August 1, 2024. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase."}],"balance_after":1981,"source":{"system":"sec-edgar","filing":"0000950170-24-099338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030709/000095017024099338/ownership.xml","form_type":"4"}}]}